Search Results
Apr 30, 2026, 08:00 ET Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis
- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory skin diseases - -
More news about: Bambusa Therapeutics
Apr 30, 2026, 08:00 ET Baltimore Community Foundation Announces Nominations Open for 2026 Neighborhood Spotlight Awards
individual, volunteer group, or nonprofit organization that has made a significant and meaningful impact in Baltimore City or Baltimore County over the past two years qualifies for nomination. Nominating a neighbor is an easy process and can be submitted at
More news about: Baltimore Community Foundation
Apr 30, 2026, 08:00 ET GTCR Announces Partnership with Brian Crotty to Form Avelis Holdings
market-leading businesses in close collaboration with leadership teams, and look forward to applying this approach at Avelis."Mr. Crotty brings more than two decades of experience building data and analytics platforms serving global energy and commodity markets. He previously served as Chief Executive Officer
More news about: GTCR
Apr 30, 2026, 08:00 ET Are You All In? Target ALS Goes "All In For ALS Awareness" with Campaign to Highlight the Community and Research Building a World Where Everyone Lives
ability to move, including breathing, swallowing, talking, and walking, among other daily activities. The life expectancy after diagnosis averages only two to five years, and current treatments provide modest benefit or apply to a limited number of cases.ALS is a devastating disease. However, this
More news about: Target ALS
Apr 30, 2026, 08:00 ET Altesa BioSciences Selected for Oral Presentation at the American Thoracic Society 2026 International Congress
greatest risk. Participants will be closely monitored over time and, upon development of rhinovirus infection, will be randomized to receive one of two doses of vapendavir or placebo. The trial's primary objective is to assess improvement in respiratory symptoms using established patient-reported outcomes,
More news about: Altesa Biosciences Inc.
Apr 30, 2026, 08:00 ET Yon Raz-Fridman Joins Intrinsic Labs as Co-Founder and Partner
Raz-Fridman has spent nearly two decades building across software, hardware, and platform businesses. Early in his career, he served as Chief of Staff to the President of Keter Group,
More news about: Team Yon LLC
Apr 30, 2026, 08:00 ET Samyang Foods Ignites the U.S. Mac & Cheese Category with Bold New Buldak Innovation
innovation to the shelf, delivering a next-generation take on Mac & Cheese designed to resonate with today's evolving consumer palate.Launching in two bold varieties, Sweet Corn Buldak Mac & Cheese and the fan-favorite Carbonara Buldak Mac & Cheese deliver a unique fusion of creamy indulgence
More news about: Samyang America
Apr 30, 2026, 08:00 ET Claros Demonstrates ≥99.99% PFAS Destruction in Groundwater from MPCA Lake Elmo Site
it."About Claros TechnologiesFounded in 2018 and based in Minneapolis, Minnesota, Claros Technologies is a global leader in PFAS mitigation, with two core divisions. The ClarosTech™ division focuses exclusively on the permanent destruction of PFAS, offering affordable, high-flow, scalable, and field-ready
More news about: Claros Technologies
Apr 30, 2026, 08:00 ET Claros Demonstrates ≥99.99% PFAS Destruction in Groundwater from MPCA Lake Elmo Site
it."About Claros TechnologiesFounded in 2018 and based in Minneapolis, Minnesota, Claros Technologies is a global leader in PFAS mitigation, with two core divisions. The ClarosTech™ division focuses exclusively on the permanent destruction of PFAS, offering affordable, high-flow, scalable, and field-ready
More news about: Claros Technologies
Apr 30, 2026, 08:00 ET Thompson Thrift Hosts Ribbon Cutting for The Liliana Near Savannah, Georgia
sought-after Savannah Quarters neighborhood just off Interstate 16 and Pooler Parkway, The Liliana consists of three-story buildings offering one-, two- and three-bedroom apartment homes with up to nearly 1,400 square feet of living space.The apartment homes feature many of the luxurious finishes
More news about: Thompson Thrift
Apr 30, 2026, 08:00 ET Optimum Nutrition Introduces New Convenient Formats to Power Everyday Performance
Optimum Nutrition, the world's #1 sports nutrition brand1 and part of Glanbia Performance Nutrition, is expanding its portfolio with two new products designed to fit today's active lifestyles. The expanded portfolio includes
More news about: Glanbia Performance Nutrition (NA), Inc.
Apr 30, 2026, 08:00 ET Casap First-Party Fraud Data Warns Losses Are Expected to Climb in 2026, Agentic AI Can Bridge the Gap
to Stop ItNearly half of all financial institutions surveyed saw fraud-related losses increase in 2025 compared to 2024, and two-thirds expect losses to climb again in 2026. Concern about fraud among bank and credit union executives has intensified, with consumer-related
More news about: Casap
Apr 30, 2026, 08:00 ET Halozyme Appoints Darren Snellgrove as Chief Financial Officer
advanced auto-injector technologies designed to improve convenience, reliability and tolerability, enhancing patient comfort and adherence. The Company has two proprietary commercial products, Hylenex® and XYOSTED®, partnered commercial products and ongoing development programs with Teva
More news about: Halozyme Therapeutics, Inc.
Apr 30, 2026, 08:00 ET Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
were deficient in the tumor. The Company's lead product candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), is being evaluated in two clinical trials as a treatment for NSCLC and SCLC. Each of Genprex's lung cancer clinical programs has received a Fast Track Designation from the FDA
More news about: Genprex, Inc.
Apr 30, 2026, 08:00 ET Arrow Reports 1st Quarter Net Income of $13.5 Million, or $0.82 per Share, and Declares 2nd Quarter Dividend of $0.30 per Share
acquisition of Adirondack Bancorp, Inc., and unification expenses, which are related to the system conversion and operational merger of the Company's two banking subsidiaries during the year ended December 31, 2025. EPS, efficiency ratio, and ROA are presented on an adjusted basis to reflect these exclusions.
More news about: Arrow Financial Corporation
Apr 30, 2026, 07:38 ET 137 Ventures Raises Over $700 Million Across Two New Funds, Surpasses $15 Billion in AUM
Ventures, a growth-stage venture firm backing companies including Anduril, Gusto, Ramp and SpaceX, today announced the close of over $700 million across two new funds, bringing total assets under management to more than $15 billion. The raise marks a significant step in the continued scaling of 137 Ventures'
More news about: 137 Ventures
Apr 30, 2026, 07:30 ET Magellan AI Announces Expanded Partnership with iHeartMedia to Bring Broadcast Radio Attribution to Advertisers
largest digital only audio service. iHeart is the largest podcast publisher according to both Podtrac and Triton, with more downloads than the next two podcast publishers combined, has the most recognizable live events across all genres of music, has the number one social footprint among audio players,
More news about: Magellan AI
Apr 30, 2026, 07:30 ET JLL Reports Financial Results for First-Quarter 2026
equity advisory activity (up nearly 80% compared with the prior-year quarter). Investment sales and debt advisory grew 27% (42% on a two-year stacked basis) and 30% (81% on a two-year stacked basis), respectively. Globally, investment sales revenue growth significantly outpaced the broader market, which grew
More news about: JLL-IR
Apr 30, 2026, 07:15 ET Mill Creek Announces Groundbreaking of Modera Garden State Plaza
Modera Garden State Plaza, which will feature 575 homes in two separately branded residential buildings, includes 48,000 square feet of ground-floor retail space and a refined suite of wellness-themed amenities.
More news about: Mill Creek Residential
Apr 30, 2026, 07:12 ET ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY
2026 the company closed the acquisition of the Infusion Business Unit of TerSera, a US based pharma company, composed of two highly specialized pharma drugs. With these two assets, ESTEVE has successfully integrated into its operations 8 new products in the last 18 months.At the same time,
More news about: ESTEVE
Apr 30, 2026, 07:00 ET RentCafe Launches ChatGPT App, Bringing Conversational Apartment Search to Renters
bringing everything into one place. Renters can describe what they're looking for, whether it's a pet-friendly apartment near downtown Austin, a spacious two-bedroom in a quiet neighborhood in Seattle under $2,000, or a studio near work available next month, and instantly receive matching listings complete
More news about: RentCafe
Apr 30, 2026, 07:00 ET T. ROWE PRICE GROUP REPORTS FIRST QUARTER 2026 RESULTS
(NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.71 trillion in client assets as of March 31, 2026, about two-thirds of which are retirement-related. Renowned for over 85 years of investment excellence, retirement leadership, and independent proprietary research,
More news about: T. Rowe Price Group
Apr 30, 2026, 07:00 ET Insmed to Present at May 2026 Investor Conferences
focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities,
More news about: Insmed Incorporated
Apr 30, 2026, 07:00 ET CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
where toxic substances are removed, and then back into the body. CytoSorbents' technologies are used in a number of broad applications. Specifically, two important applications are 1) the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and 2) the
More news about: Cytosorbents Corp
Apr 30, 2026, 07:00 ET Phoenix launches ambitious Quantum Strategy, taps ASU's Panchanathan to lead the effort
pilot, expanding access to critical infrastructure for researchers and educators nationwide.Prior to his time at NSF, Panchanathan spent more than two decades at ASU, where he founded major academic programs and research centers, including the Center for Cognitive Ubiquitous Computing and the School
More news about: Arizona State University - Media Relations